CTOs on the Move

Symbiomix Therapeutics

www.symbiomix.com

 
Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.symbiomix.com
  • 105 Lock Street Suite 409
    Newark, NJ USA 07103-3576
  • Phone: 609.722.7250

Executives

Name Title Contact Details

Funding

Symbiomix Therapeutics raised $41M on 05/06/2015

Similar Companies

Inovise Medical

Inovise Medical is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Partners Technology Inc

Health Partners Technology Inc is a Stoneham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EverestLabs

EverestLabs is a company that uses AI, robotics, and automation to help material recovery facilities (MRFs) operate more efficiently and enabling CPG brands to exceed their recycled content, EPR and ESG goals.

Medical Transactions

Medical Transactions is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Clinomed Inc

Clinomed Inc is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.